CN1268027A - 草本提取物的化学和药理学标准化方法 - Google Patents

草本提取物的化学和药理学标准化方法 Download PDF

Info

Publication number
CN1268027A
CN1268027A CN98808588A CN98808588A CN1268027A CN 1268027 A CN1268027 A CN 1268027A CN 98808588 A CN98808588 A CN 98808588A CN 98808588 A CN98808588 A CN 98808588A CN 1268027 A CN1268027 A CN 1268027A
Authority
CN
China
Prior art keywords
extract
test
chemical
pharmacological activity
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98808588A
Other languages
English (en)
Chinese (zh)
Inventor
彼得·K·T·庞
杰奎琳·J·单
卡姆·W·丘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Afexa Life Sciences Inc
Original Assignee
CV Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Technologies Inc filed Critical CV Technologies Inc
Publication of CN1268027A publication Critical patent/CN1268027A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
CN98808588A 1997-08-28 1998-08-28 草本提取物的化学和药理学标准化方法 Pending CN1268027A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5609297P 1997-08-28 1997-08-28
US60/056,092 1997-08-28

Publications (1)

Publication Number Publication Date
CN1268027A true CN1268027A (zh) 2000-09-27

Family

ID=22002097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98808588A Pending CN1268027A (zh) 1997-08-28 1998-08-28 草本提取物的化学和药理学标准化方法

Country Status (8)

Country Link
US (1) US6156291A (https=)
EP (1) EP1006802A4 (https=)
JP (2) JP4520033B2 (https=)
KR (1) KR20010023208A (https=)
CN (1) CN1268027A (https=)
AU (1) AU9029298A (https=)
CA (1) CA2301860C (https=)
WO (1) WO1999009837A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188724A (zh) * 2013-03-14 2015-12-23 张宗超 用于测定草药的活性成分及其产生的来源和催化途径的方法

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
BR9909110A (pt) * 1998-03-26 2000-12-12 Phytopharm Plc Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
KR20020035855A (ko) 1999-08-30 2002-05-15 마쯔오 미쯔요시 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
JP2001139483A (ja) * 1999-08-30 2001-05-22 Japan Science & Technology Corp 薬用人蔘からなる脳細胞または神経細胞保護剤
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US6884627B2 (en) * 2002-04-05 2005-04-26 Advanced Gene Technology, Corp. Method for ascertaining the quality of herbs
US6855343B2 (en) 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
EP1570250A4 (en) * 2002-10-25 2007-03-14 Sloan Kettering Inst Cancer SCREENING, QUANTIFICATION AND IDENTIFICATION OF ACTIVE PRINCIPLES IN NATURAL PRODUCTS
US7491753B2 (en) 2003-07-03 2009-02-17 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
JP2008506686A (ja) * 2004-07-16 2008-03-06 ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク ベータ−アミロイドペプチドの形成を阻害することによるアルツハイマー病治療用化合物及び製造
TWI285262B (en) * 2005-06-20 2007-08-11 Dev Center Biotechnology Characteristic mass spectrum fingerprinting setting method and rapid identification method of Chinese herb medicine and prescription
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
CA2661486C (en) 2006-08-24 2013-04-23 Mallard Creek Polymers, Inc. Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
CA2672408C (en) * 2007-03-30 2019-07-23 9898 Limited Pharmacokinetic and pharmacodynamic modelling and methods for the development of phytocompositions or other multi-component compositions
AU2009206753B2 (en) 2008-01-24 2014-07-03 Raptor Therapeutics Inc. Protopanaxadiol-type ginsenoside compositions and uses thereof
CN102014941B (zh) * 2008-02-29 2013-11-06 阿费克萨生命科学公司 人参提取物对固有及适应性免疫应答的激活
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
KR20110007473A (ko) * 2009-07-16 2011-01-24 씨제이제일제당 (주) 진세노사이드 강화 분획물을 포함하는 혈압 강하용 조성물
JP5563285B2 (ja) * 2009-12-14 2014-07-30 ライオン株式会社 飲食品、医薬品、又は医薬部外品、並びに、プロトパナキサトリオールの安定化方法、及びプロトパナキサジオールの安定化方法
US20110177179A1 (en) * 2010-01-18 2011-07-21 Sinoveda Canada, Inc. Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology
US20150044306A1 (en) 2013-08-12 2015-02-12 Melvin Mitchell Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals
US20160085941A1 (en) * 2015-03-13 2016-03-24 Jianyi Zhang Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis
WO2018222622A1 (en) 2017-05-27 2018-12-06 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
PL3638740T3 (pl) 2017-06-16 2024-10-14 Poly Group LLC Polimerowy przeciwdrobnoustrojowy środek powierzchniowo czynny
EP4025231B1 (en) 2019-09-03 2024-08-28 Botalys SA Ginseng composition and use thereof as a medicament
BE1027772B1 (fr) 2019-11-21 2021-06-21 Botalys Sa Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique
BE1027552B1 (fr) 2019-09-03 2021-03-30 Botalys Sa Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress
WO2021043389A1 (en) 2019-09-03 2021-03-11 Botalys Sa Ginseng composition and use thereof as a medicament for treatment or prevention of an impaired cognition
US10881983B2 (en) * 2019-09-18 2021-01-05 The Winning Combination Method for extraction of ethyl maltol from passion flower

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753397A (ja) * 1993-08-19 1995-02-28 Inahata Koryo Kk 変異原性抑制剤
JPH07126618A (ja) * 1993-11-04 1995-05-16 Jumoku Chushutsu Seibun Riyou Gijutsu Kenkyu Kumiai 抗酸化剤
US5547674A (en) * 1995-04-14 1996-08-20 University Of Southern California Pharmaceutical preparations derived from European mistletoe
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
JPH11503453A (ja) * 1995-04-14 1999-03-26 ユニバーシティー オブ サザン カリフォルニア ヤドリギ抽出物および方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188724A (zh) * 2013-03-14 2015-12-23 张宗超 用于测定草药的活性成分及其产生的来源和催化途径的方法

Also Published As

Publication number Publication date
JP2001513533A (ja) 2001-09-04
WO1999009837A1 (en) 1999-03-04
CA2301860A1 (en) 1999-03-04
CA2301860C (en) 2009-05-26
AU9029298A (en) 1999-03-16
US6156291A (en) 2000-12-05
KR20010023208A (ko) 2001-03-26
EP1006802A1 (en) 2000-06-14
JP5491114B2 (ja) 2014-05-14
JP2009292844A (ja) 2009-12-17
JP4520033B2 (ja) 2010-08-04
EP1006802A4 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
CN1268027A (zh) 草本提取物的化学和药理学标准化方法
US6083932A (en) Pharmaceutical compositions derived from ginseng and methods of treatment using same
JP5906267B2 (ja) 学習・記憶障害および運動障害などを伴う中枢神経変性疾患を改善する乾燥植物組織および植物組織抽出物ならびにこれらを含有する医薬品および食品
Xue et al. Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory
US7338675B2 (en) Fenugreek seed bio-active compositions and methods for extracting same
Nan et al. Wuzhuyu decoction relieves hyperalgesia by regulating central and peripheral 5-HT in chronic migraine model rats
CN1621836A (zh) 生脉注射剂的质量控制方法
CN112618614B (zh) 一种具有抗抑郁症的刺梨活性提取物及应用
Lin et al. Cordyceps militaris and Armillaria mellea formula alleviates depressive behaviors via microglia regulation in an unpredictable chronic mild stress animal model
Hong et al. Ethyl acetate extract of Nymphaea candida Presl: A potential anti-depressant and neuroprotective treatment strategy
KR102041847B1 (ko) 물푸레나무 추출물을 유효성분으로 포함하는 우울증 및 불안장애의 예방, 개선 또는 치료용 조성물
CN1765374A (zh) 灵芝咀嚼片的制备方法及产品
Zhu et al. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson’s disease mice after oral administration of Wen-Shen-Yang-Gan decoction
CN101062113A (zh) 一种远志提取物及其制备方法和用途
Mădălina-Georgiana et al. Assessing β-sitosterol levels in dietary supplements for benign prostatic hyperplasia: implications for therapeutic efficacy
CN1186351C (zh) 黄花倒水莲总皂苷及其药物组合物与制备方法
Yang et al. Effects of Chinese herbal medicine Fuzhisan on autologous neural stem cells in the brain of SAMP-8 mice
HK1027946A (en) Chemical and pharmacological standardization of herbal extracts
Shi et al. Kai-Xin-San improves CUMS-induced depression by regulating the tryptophan-5-hydroxytryptophan-5-HT pathway
Xu et al. HPLC Fingerprint Analysis of Rana chensinensis Eggs from Different Habitats and Their Antitussive Effect
Jung et al. Dendropanax morbifera Léveille extract ameliorates memory impairments and inflammatory responses in the hippocampus of streptozotocin-induced type 1 diabetic rats
CN114209718B (zh) 海马提取物的制备方法及其应用
CN1824126A (zh) 滋阴补肾的口服制剂的质量控制方法
Ji et al. Improvement of Ganoderma lucidum water extract on the learning and memory impairment and its mechanism in d-galactose-induced aging mice
Shweta et al. Morpho-anatomy, physicochemical and phytochemical standardization with HPTLC fingerprinting of aerial parts of Rivea hypocrateriformis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1027946

Country of ref document: HK